Jaspr Health Expands & Extends Pilot Testing of Industry’s 1st Digital Suicide Care Platform to Help Save Lives

Extended to Primary Care with National Institute on Alcohol Abuse and Alcoholism (NIAAA) Funding; Allina Health Partnership Expands Emergency Department Partnerships

Jaspr Health, the first scientifically-validated, suicide-specific digital care platform, today announced the expansion of its pilot program in Emergency Departments (EDs) via a partnership with Allina Health, along with the expansion of use to primary care settings via a $2.1M grant from the National Institute on Alcohol Abuse and Alcoholism (NIAAA).

Jaspr Health tablet and mobile applications bolster capacity and speed recommended, evidence-based care – assessments and interventions that have been rigorously evaluated and shown to produce positive impacts – with its automated assistant’s on-demand guided assessments, crisis stability planning, hope-inspiring videos of survivors with lived experiences and a library of coping skills.

Staffing shortages across the nation have made it difficult for EDs and primary care clinics to provide suicide care to those in need. Today, the lack of qualified ED staff can delay care of a person in suicide crisis by as much as 12 hours. Even before COVID, behavioral health emergency care took three times longer than other health emergencies. When finally received, this care is often below-standard for patients and expensive for healthcare systems.

“EDs have seen an overwhelming increase in behavior health emergencies over the last decade – a staggering 14 million per year and growing at 12 percent. Exactly as with a stroke or heart attack patient, the immediate, and the right emergency care, can save the life of a person in suicide crisis,” said Dr. Kelly Koerner, Jaspr Health CEO and founder. “Jaspr was designed to support providers and enable them to reliably deliver the right care quickly. We are thrilled to extend our success in the ED to primary care and expand features to help people with problem drinking.”

Jaspr’s Solution

Jaspr Health is patient-endorsed, peer-reviewed and rigorously tested. The applications were designed by suicide science experts, people with lived experience, and leading health systems to help save lives by providing immediate, compassionate suicide care. Using standardized, evidence-based protocols to help stabilize patients, including suicide risk assessments and crisis stability planning, hospitals can decrease downstream costs and ensure continuity of care.

With integration into electronic health records, workloads are decreased and patient engagements can be optimized and adjusted to improve quality. The solution also offers ED staff the just-in-time training critical to building confidence and skill sets to effectively help patients in crisis. Overall, Jaspr Health aims to improve the patient experience, while helping health systems reduce risks and costs, without any increased burden on healthcare providers.

In National Institute of Health (NIH) funded clinical trials, Jaspr outperformed traditional care in the ER, enabling increased access to evidence-based, suicide-specific interventions, increased ability for patients to cope with suicidal thoughts, decreased patient distress and agitation, and increased reports from patients of learning skills to regulate their emotions. The solution is currently being piloted in nearly 20 EDs across the nation, and will expand testing into primary care clinics as well as to individuals with alcohol use disorders, often associated with both an exponential increase in suicide risk and interference in suicide prevention efforts.

For more information on the features and benefits of Jaspr Health’s tablet and mobile applications, click here.

Jaspr Health Partnerships

The company’s new partnership with Allina Health will help reduce the growing rate of suicide throughout the Minnesota and Western Wisconsin area. This five-year partnership will include the use of Jaspr Health for people acutely at risk for suicide and seeking psychiatric crisis services from one of Allina Health’s 12 EDs.

The grant from NIAAA generates the funding necessary for Jaspr to extend trials into primary care clinics, and expand to include patients with alcohol use disorders, which result in a tenfold increase of suicide risk and interfere with suicide prevention efforts.

These announcements follow on the heels of its relationship with the Zero Suicide Institute to integrate awareness, education and support to help save lives. This Fall, the organizations will jointly launch new educational programs and content for health systems highlighting how digital technology can significantly improve the standardization of compassionate, personalized and evidence-based care.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”